BioCryst Pharmaceuticals Inc. (BCRX)
NASDAQ · Healthcare
BioCryst Pharmaceuticals Inc. annual/quarterly long term debt history from 2016 to 2024. Long term debt refers to financial obligations that are due more than one year in the future.
- BioCryst Pharmaceuticals Inc. long term debt for the quarter ending December 31, 2024 were 314.9M, a 3.84% increase year-over-year.
- BioCryst Pharmaceuticals Inc. long term debt for 2024 were 314.9M, a 3.84% increase from 2023.
- BioCryst Pharmaceuticals Inc. long term debt for 2023 were 303.2M, a 30.92% increase from 2022.
- BioCryst Pharmaceuticals Inc. long term debt for 2022 were 231.6M, a 22.31% decrease from 2021.
- BioCryst Pharmaceuticals Inc. long term debt for 2021 were 298.1M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| BioCryst Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2024 | $315 |
| 2023 | $303 |
| 2022 | $232 |
| 2021 | $298 |
| 2020 | $123 |
| 2019 | $50 |
| 2018 | $30 |
| 2017 | $23 |
| 2016 | $23 |
| BioCryst Pharmaceuticals Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2024-12-31 | $315 |
| 2023-12-31 | $303 |
| 2022-12-31 | $232 |
| 2021-12-31 | $298 |
| 2020-12-31 | $123 |
| 2019-12-31 | $50 |
| 2018-12-31 | $30 |
| 2017-12-31 | $23 |
| 2016-12-31 | $23 |
BioCryst Pharmaceuticals Inc. Long Term Debt — FAQ
BioCryst Pharmaceuticals Inc. (BCRX) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BCRX's long term debt history?
The chart and table above show BioCryst Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.